Anti-HDV and HDV-RNA prevalence in HBsAg positive blood samples prospectively collected in the hepatitis B screening within the Check-Up35+” in the German primary care setting after implementation by the Federal Joint Committee (G-BA)
- Conditions
- B17.0Acute delta-(super)infection in chronic hepatitis B
- Registration Number
- DRKS00029180
- Lead Sponsor
- niversitätsklinikum LeipzigKlinik für Gastroenterologie
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 225901
Inclusion Criteria
for the prospective part of the study:
- Age 18-99 years
- HBsAg positive result within the Check-Up35+
- written informed consent for the analysis of HDV-RNA and documentation of clinical parameters
for the retrospective part of the study:
- Age 18-99 years
- HBsAg positive result within the routine diagnostic evaluation of primary care physicians
Exclusion Criteria
no specific exclusion criteria
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method prevalence of anti-HDV in HBsAg positive individuals in the prospectively analysed blood samples of the Check-Up 35+”
- Secondary Outcome Measures
Name Time Method - prevalence of HDV-RNA in HBsAg and anti-HDV positive individuals in the prospectively analysed blood samples of the Check-Up 35+”<br>- prevalence of anti-HDV in HBsAg positive individuals in the retrospective LADR database analysis<br>- prevalence of HDV-RNA in HBsAg and anti-HDV positive individuals in the retrospective LADR database analysis<br>- anti-HDV screening rate in HBsAg positive patients by primary care physicians in Germany<br>